| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 4.272 | 251.233 |
| Total Income - EUR | - | - | - | - | - | - | - | 0 | 4.272 | 251.291 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 137 | 12.085 | 284.651 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -137 | -7.813 | -33.360 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -137 | -7.856 | -33.629 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 4 |
Check the financial reports for the company - Lactosib S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 598 | 28.340 | 35.282 |
| Current Assets | - | - | - | - | - | - | - | 7.648 | 4.061 | 41.416 |
| Inventories | - | - | - | - | - | - | - | 7.055 | 1.222 | 23.490 |
| Receivables | - | - | - | - | - | - | - | 310 | 1.397 | 8.264 |
| Cash | - | - | - | - | - | - | - | 283 | 1.442 | 9.661 |
| Shareholders Funds | - | - | - | - | - | - | - | -96 | -7.952 | -41.537 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 8.342 | 40.353 | 118.235 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1051 - 1051" | |||||||||
| CAEN Financial Year |
1051
|
|||||||||
Comments - Lactosib S.r.l.